MTOR and lung cancer: In parallel to oxidative stress, oncogenic mutations in lung cancer can also induce HIF activation, e.g., phosphatase and tensin homolog (PTEN), PI3K/Akt/mTOR pathway (152, 173), or epigenetic alterations (174, 175).